Posted in | News | Lithium

Nemaska Lithium Announces Filing of Feasibility Study on Whabouchi Mine and Concentrator

Nemaska Lithium Inc. («Nemaska» or the «Corporation») announced today that it has filed its Feasibility Study on the Whabouchi Mine and Concentrator to be located in the Eeyou Istchee / James Bay Region of Quebec and the Hydromet Plant to be located in Salaberry-de-Valleyfield, Quebec.

"Initial reaction from the industry (lithium end users and strategic partners) to the highlights of the Feasibility Study released on May 13, 2014 was very positive," commented Guy Bourassa, President and CEO. "With the filing of the Feasibility Study report, we are now on track to continue discussions with potential end users and partners that were waiting for the details of the report before furthering their review of the project." Mr. Bourassa continued, "We are seeing a growing interest in lithium hydroxide from a number of end users in need of high a purity lithium hydroxide product."

Lithium hydroxide is emerging as the chemical compound of choice for the growing lithium-ion battery market due to several factors including: a longer life cycle; better power density (last longer between charges) and enhanced safety features (more tolerant to temperature changes, especially high heat).

About Nemaska

Nemaska intends to become a lithium hydroxide and lithium carbonate producer based in Quebec and has filed patent applications for its proprietary methods to produce these compounds. In tandem, the Corporation is developing one of the richest spodumene lithium hard rock deposit in the world, both in volume and grade. Spodumene concentrate produced at Nemaska's Whabouchi mine and from other global sources will be shipped to the Corporation's lithium compounds processing plant to be built in Salaberry-de-Valleyfield, Quebec. This plant will transform spodumene concentrate into high purity lithium hydroxide and lithium carbonate mainly for the growing lithium battery market.

Source: http://www.nemaskaexploration.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.